CPIX — Cumberland Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Cumberland Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	28.2	24.8	27	19.8	18.3
Net Total Accounts Receivable
Net Total Receivables	9.78	12.4	6.88	13.2	9.76
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	50.2	50	45.7	45.9	35.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.71	2.6	1.47	5.5	7.04
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	105	96.5	84.5	92.9	81.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	24.2	25.7	19.3	28.6	28
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	53.4	49.5	41.6	56.7	52.2
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	51.1	47	42.8	36.3	29.6
Total Liabilities & Shareholders' Equity	105	96.5	84.5	92.9	81.8
Total Common Shares Outstanding